阅读说明：本技术 施用某些vmat2抑制剂的方法 (Methods of administering certain VMAT2 inhibitors ) 是由 克里斯托弗·F·奥勃良 黑格·P·博齐根 于 2017-10-10 设计创作，主要内容包括：提供了向有需要的患者施用选自缬苯那嗪和(+)-α-3-异丁基-9,10-二甲氧基-1,3,4,6,7,11b-六氢-2H-吡啶并[2,1-a]异喹啉-2-醇或其药物可接受的盐和/或同位素变体的囊泡单胺转运体2(VMAT2)抑制剂的方法,其中所述患者还正在被施用细胞色素P450 3A4(CYP3A4)强抑制剂。(Methods of administering a vesicular monoamine transporter 2(VMAT2) inhibitor selected from valbenazine and (+) - α -3-isobutyl-9, 10-dimethoxy-1, 3,4,6,7,11 b-hexahydro-2H-pyrido [2,1-a ] isoquinolin-2-ol, or pharmaceutically acceptable salts and/or isotopic variants thereof, to a patient in need thereof are provided, wherein said patient is also being administered a strong inhibitor of cytochrome P4503a4(CYP3a 4).)